Company Boule Diagnostics AB

Equities

BOUL

SE0011231158

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:24:58 2024-04-29 am EDT 5-day change 1st Jan Change
10.1 SEK +3.06% Intraday chart for Boule Diagnostics AB +4.99% -9.98%

Business Summary

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.

Number of employees: 228

Sales per Business

SEK in Million2022Weight2023Weight Delta
Consumables to Own Instruments
40.8 %
233 42.5 % 233 40.8 % +0.16%
Instruments
32.1 %
159 28.9 % 184 32.1 % +15.78%
Consumable Original Equipment Manufacturer and Clinical Diagnostic Solutions-Brand
20.0 %
113 20.5 % 114 20.0 % +1.32%
Other
7.1 %
44 8.0 % 40 7.1 % -8.21%

Sales per region

SEK in Million2022Weight2023Weight Delta
United States
34.9 %
190 34.6 % 199 34.9 % +4.92%
Asia
29.6 %
151 27.5 % 169 29.6 % +12.35%
Africa/ Middle East
10.8 %
-- 62 10.8 % -
Latin America
9.0 %
45 8.2 % 52 9.0 % +14.52%
Western Europe
8.9 %
40 7.2 % 51 8.9 % +28.08%
Eastern Europe
6.8 %
62 11.4 % 39 6.8 % -38.05%

Managers

Managers TitleAgeSince
Director of Finance/CFO - Dec. 31
Human Resources Officer - 22-09-30
Corporate Officer/Principal - 11-12-31
General Counsel - 16-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 71 20-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
Director/Board Member 65 14-12-31
Director/Board Member 35 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,833,104 23,948,273 ( 61.67 %) 0 61.67 %

Shareholders

NameEquities%Valuation
Nordea Investment Management AB
9.588 %
3,723,341 9.588 % 3 M kr
Swedbank Robur Fonder AB
9.233 %
3,585,296 9.233 % 3 M kr
3,450,934 8.887 % 3 M kr
Svolder AB (Investment Management)
8.780 %
3,409,359 8.780 % 3 M kr
2,762,368 7.113 % 3 M kr
Tredje AP-fonden
5.912 %
2,295,936 5.912 % 2 M kr
Aktia Fondbolag Ab
2.556 %
992,540 2.556 % 921 752 kr
Andra AP-fonden
2.491 %
967,329 2.491 % 898 339 kr
Eccenovo AB
0.8006 %
310,911 0.8006 % 288 737 kr
Aktia Varainhoito Oy
0.4546 %
176,527 0.4546 % 163 937 kr

Company contact information

Boule Diagnostics AB

Domnarvsgatan 4

163 53, Spanga

+46 87 44 77 00

http://www.boule.se
address Boule Diagnostics AB(BOUL)
  1. Stock Market
  2. Equities
  3. BOUL Stock
  4. Company Boule Diagnostics AB